` CRL (Charles River Laboratories International Inc) vs 207940 (Samsung Biologics Co Ltd) Comparison - Alpha Spread

CRL
vs
207940

Over the past 12 months, CRL has underperformed Samsung Biologics Co Ltd, delivering a return of -22% compared to the Samsung Biologics Co Ltd's +26% growth.

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
CRL
207940
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Valuation
Growth
Profitability
Solvency
Comparing Valuation
Running a multi-layered valuation analysis to compare how attractive each stock is.
Comparing Growth
Financial growth, forecasts, volatility, and historical drawdowns.
Comparing Profitability
Margins, returns on capital, and the consistency of profitability.
Comparing Solvency
Debt levels, liquidity, interest coverage, and bankruptcy risk.
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

CRL Intrinsic Value
207.58 USD
Undervaluation 24%
Intrinsic Value
Price
Intrinsic Value
672 532.4632 KRW
Overvaluation 33%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Charles River Laboratories International Inc
NYSE:CRL
157.12 USD
Samsung Biologics Co Ltd
KRX:207940
999 999.9999 KRW
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
CRL vs 207940

CRL
207940
Add Stock
Revenue
www.alphaspread.com
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Charles River Laboratories International Inc
Revenue
Samsung Biologics Co Ltd
Revenue

All metrics are calculated based on data from the last 10 years.

Profitability Comparison

Free Cash Flow
CRL vs 207940

CRL
207940
Add Stock
Free Cash Flow
www.alphaspread.com
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Charles River Laboratories International Inc
NYSE:CRL
Samsung Biologics Co Ltd
KRX:207940
What is Free Cash Flow?

Gross Margin

CRL
34.7%
Samsung Biologics Co Ltd
53.2%

Operating Margin

CRL
12.6%
Samsung Biologics Co Ltd
32.4%

Net Margin

CRL
-0.8%
Samsung Biologics Co Ltd
26.1%

FCF Margin

CRL
14%
Samsung Biologics Co Ltd
2.8%

ROE

CRL
-0.9%
Samsung Biologics Co Ltd
12%

ROA

CRL
-0.4%
Samsung Biologics Co Ltd
7.5%

ROIC

CRL
-5.3%
Samsung Biologics Co Ltd
8.2%

ROCE

CRL
7.4%
Samsung Biologics Co Ltd
12.3%

Solvency Comparison

Balance Sheet Comparison

Stocks Performance

Stocks Performance
CRL vs 207940

Loading

Performance Gap
CRL vs 207940

Loading
CRL
207940
Difference
www.alphaspread.com

Performance By Year
CRL vs 207940

Loading
CRL
207940
Add Stock
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare CRL to other stocks
Unlock Full Access to Alpha Spread
Create Free Account